These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19958395)

  • 81. Endothelial progenitor cells as therapeutic agents in the microcirculation: an update.
    Napoli C; Hayashi T; Cacciatore F; Casamassimi A; Casini C; Al-Omran M; Ignarro LJ
    Atherosclerosis; 2011 Mar; 215(1):9-22. PubMed ID: 21126740
    [TBL] [Abstract][Full Text] [Related]  

  • 82. [Platelet derived growth factor receptor β over-expression in endothelial progenitor cells promote reendothelialization after vascular injury].
    Wang H; Huang H; Yin Y; Deng M; Kang H; Huang L
    Zhonghua Xin Xue Guan Bing Za Zhi; 2014 Mar; 42(3):214-8. PubMed ID: 24831478
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Endothelial progenitor cells: a novel tool for the therapy of ischemic diseases.
    Alev C; Ii M; Asahara T
    Antioxid Redox Signal; 2011 Aug; 15(4):949-65. PubMed ID: 21254837
    [TBL] [Abstract][Full Text] [Related]  

  • 84. A novel hypothesis of atherosclerosis: EPCs-mediated repair-to-injury.
    Zhang M; Zhou SH; Li XP; Shen XQ; Fang ZF
    Med Hypotheses; 2008; 70(4):838-41. PubMed ID: 17920780
    [TBL] [Abstract][Full Text] [Related]  

  • 85. The promise of EPC-based therapies on vascular dysfunction in diabetes.
    Georgescu A; Alexandru N; Constantinescu A; Titorencu I; Popov D
    Eur J Pharmacol; 2011 Nov; 669(1-3):1-6. PubMed ID: 21839073
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Effect of prepro-calcitonin gene-related peptide-expressing endothelial progenitor cells on pulmonary hypertension.
    Zhao Q; Liu Z; Wang Z; Yang C; Liu J; Lu J
    Ann Thorac Surg; 2007 Aug; 84(2):544-52. PubMed ID: 17643632
    [TBL] [Abstract][Full Text] [Related]  

  • 87. The emerging role of endothelial progenitor cells in pulmonary hypertension and diffuse lung diseases.
    Fadini GP; Schiavon M; Avogaro A; Agostini C
    Sarcoidosis Vasc Diffuse Lung Dis; 2007 Sep; 24(2):85-93. PubMed ID: 18496977
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.
    Fan Y; Shen F; Frenzel T; Zhu W; Ye J; Liu J; Chen Y; Su H; Young WL; Yang GY
    Ann Neurol; 2010 Apr; 67(4):488-97. PubMed ID: 20437584
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Defining human endothelial progenitor cells.
    Yoder MC
    J Thromb Haemost; 2009 Jul; 7 Suppl 1():49-52. PubMed ID: 19630767
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Regenerative pulmonary medicine: potential and promise, pitfalls and challenges.
    Anversa P; Perrella MA; Kourembanas S; Choi AM; Loscalzo J
    Eur J Clin Invest; 2012 Aug; 42(8):900-13. PubMed ID: 22435680
    [TBL] [Abstract][Full Text] [Related]  

  • 91. New trial designs and potential therapies for pulmonary artery hypertension.
    Gomberg-Maitland M; Bull TM; Saggar R; Barst RJ; Elgazayerly A; Fleming TR; Grimminger F; Rainisio M; Stewart DJ; Stockbridge N; Ventura C; Ghofrani AH; Rubin LJ
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D82-91. PubMed ID: 24355645
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Endothelial progenitor cells in cardiovascular disease and chronic inflammation: from biomarker to therapeutic agent.
    Grisar JC; Haddad F; Gomari FA; Wu JC
    Biomark Med; 2011 Dec; 5(6):731-44. PubMed ID: 22103609
    [TBL] [Abstract][Full Text] [Related]  

  • 93. EPCs in vascular repair: how can we clear the hurdles between bench and bedside?
    Lu C; Zhang J; Zhang D; Uzan G; Li M
    Front Biosci (Landmark Ed); 2014 Jan; 19(1):34-48. PubMed ID: 24389171
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Blood-based biomarkers and stem cell therapy in human stroke: a systematic review.
    Palà E; Bustamante A; Jolkkonen J; Hommel M; Rosell A; Montaner J
    Mol Biol Rep; 2020 Aug; 47(8):6247-6258. PubMed ID: 32638318
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Novel insights into the potential applications of stem cells in pulmonary hypertension therapy.
    Guo S; Wang D
    Respir Res; 2024 Jun; 25(1):237. PubMed ID: 38849894
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells.
    Kaneko Y; Tajiri N; Shinozuka K; Glover LE; Weinbren NL; Cortes L; Borlongan CV
    Curr Pharm Des; 2012; 18(25):3731-4. PubMed ID: 22574986
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Cell-based therapies in pulmonary hypertension: who, what, and when?
    Majka S; Burnham E; Stenmark KR
    Am J Physiol Lung Cell Mol Physiol; 2011 Jul; 301(1):L9-L11. PubMed ID: 21515661
    [No Abstract]   [Full Text] [Related]  

  • 98. Modulation of EPC: A new hope for pulmonary artery hypertension treatment.
    Wang T; Hong C; Chen L; Yuan M; Wang J; Lu W
    Int J Cardiol; 2018 Oct; 268():214. PubMed ID: 30041789
    [No Abstract]   [Full Text] [Related]  

  • 99. Role of endothelial progenitor cells in cerebral aneurysm pathogenesis.
    Ding D
    Neurol Sci; 2014 Jun; 35(6):945-6. PubMed ID: 24535452
    [No Abstract]   [Full Text] [Related]  

  • 100. Stem Cell-derived Nanovesicles for the Treatment of Pulmonary Hypertension: Are We There Yet?
    Goncharova EA; Farkas L
    Am J Respir Cell Mol Biol; 2022 Jul; 67(1):3-5. PubMed ID: 35522729
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.